Not finding it? Sign in to also search OpenAlex live.
-
Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC2021 PLoS ONE article Biochemistry, Genetics and Molecular Biology MicroRNA in disease regulation Open access
Sven Heiko Loosen, M. Castoldi, Markus Sebastian Jördens, Sanchary Roy, Mihael Vucur, Jennis Kandler, +7 more
16citations -
Liver transplantation for HCC in cirrhosis: Are Milan criteria outdated?2024 Zeitschrift für Gastroenterologie article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Michael Linecker, Felix Braun, Jan-Paul Gundlach, Mark Ellrichmann, Marieke van Rosmalen, Serge Vogelaar, +5 more
5citations -
727TiP A randomised phase III study of tremelimumab (T) plus durvalumab (D) with or without lenvatinib combined with concurrent transarterial chemoembolisation (TACE) versus TACE alone in patients (pts) with locoregional hepatocellular carcinoma (HCC): EMERALD-32022 Annals of Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Ghassan K. Abou-Alfa, Junbai Fan, Jeong Heo, Y. Arai, J.P. Erinjeri, Christiane Katharina Kuhl, +4 more
19citations -
Post-Transplant HCC Recurrence and Survival: Impact of Bridging Therapy and Tumor Biology in 185 Consecutive Liver Transplants2026 Journal of Clinical Medicine article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Bengt Arne Wiemann, Clara Antonia Weigle, Julian Palzer, Philipp Tessmer, Oliver Beetz, Dennis Kleine-Döpke, +5 more
0citations -
Abstract 5876: Sorafenib and Lenvatinib induce vascular responses in patient derived HCC on-Chip models2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Angiogenesis and VEGF in Cancer
Orsola Mocellin, Abbie Robinson, Aleksandra Olczyk, Stéphane Treillard, Thomas Olivier, Chee Ping Ng, +9 more
1citations -
Bone Morphogenetic Protein (BMP)-9: a hepatic cytokine with potentially tumour-suppressive function in hepatocellular carcinoma (HCC)2022 Zeitschrift für Gastroenterologie article Biochemistry, Genetics and Molecular Biology TGF-β signaling in diseases
Katja Breitkopf‐Heinlein, Qian Zhou, Yang Zheng, Haristi Gaitantzi, Timo Itzel, A Teufel, +3 more
0citations -
Upcoming expression of ALK1 in HCC determines the switch from tumour-suppressive to tumour-promoting BMP-9 signalling2021 Zeitschrift für Gastroenterologie conference-paper Biochemistry, Genetics and Molecular Biology TGF-β signaling in diseases
Haristi Gaitantzi, Timo Itzel, A Teufel, Steven Dooley, Lukas J.A.C. Hawinkels, Emrullah Birgin, +2 more
0citations -
Macrophage Migration Inhibitory Factor promotes HCC progression in vivo via the receptor CD742020 Zeitschrift für Gastroenterologie conference-paper Immunology and Microbiology Macrophage Migration Inhibitory Factor
David P. Heinrichs, TH Wirtz, Alena Saal, Ilka Bergmann, Petra Fischer, EF Brandt, +3 more
0citations -
Proteomic subtyping highlights tumor heterogeneity of human HCC2025 Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Jovan Tanevski, Jana Baues, Sven Heiko Loosen, Tom Luedde, Ulf P. Neumann, Peter Boor, +3 more
1citations -
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Feifei Guo, Olga Estévez‐Vázquez, Raquel Benedé‐Ubieto, Douglas Maya‐Miles, Kang Zheng, Rocío Gallego‐Durán, +22 more
39citations -
Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems2020 Langenbeck s Archives of Surgery article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Jan Bednarsch, Zoltán Czigány, Daniel Heise, Katharina Joechle, Tom Luedde, Lara Rosaline Heij, +4 more
24citations -
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC2023 Neoplasia article Biochemistry, Genetics and Molecular Biology PI3K/AKT/mTOR signaling in cancer Open access
Andreas Kroh, Jeanette Walter, Athanassios Fragoulis, Diana Möckel, Twan Lammers, Fabian M. Kiessling, +10 more
8citations -
Time to surgery is not an oncological risk factor in HCC patients undergoing liver resection2023 Langenbeck s Archives of Surgery article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Carlos Constantin Otto, Anna Mantas, Daniel Heise, Philipp Bruners, Sven Arke Lang, Tom Florian Ulmer, +3 more
2citations -
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)2024 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Pim Hendriks, Daphne D. D. Rietbergen, Arian R. van Erkel, Minneke J. Coenraad, Mark J. Arntz, Roel J. Bennink, +18 more
9citations -
Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)2022 CardioVascular and Interventional Radiology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Pim Hendriks, Daphne D. D. Rietbergen, Arian R. van Erkel, Minneke J. Coenraad, Mark J. Arntz, Roel J. Bennink, +17 more
5citations